Economic impact of macrosomia

Dr Nuijten, CEO of a2m, is a pioneer in the field of nutrition-economics and has been the first classical health economist applying and developing health economic methodologies to nutritionals. He is founder of the ISPOR Special Interest Group “Nutrition Economics” and recently published his 15th scientific paper in nutrition economics, titled “Health economic modelling to assess short-term costs of maternal overweight, gestational diabetes and related macrosomia” in Frontiers in Pharmacology. This pilot study shows the initial results of ongoing health economic modelling research projects in this area.